In search of potent 5-HT6 receptor inverse agonists

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• The 5-HT6 receptor is a promising target for treating central nervous system disorders.
• Developing selective and brain-penetrant ligands is crucial for therapeutic applications.
• Non-sulfonamide/non-sulfone scaffolds offer alternative chemical space for 5-HT6 receptor modulation.

Discussion:

• A novel series of 5-HT6 receptor inverse agonists were synthesized and evaluated.
• Compound 9 demonstrated potent inverse agonism (Ki = 14 nM) and selectivity.
• Compound 9 exhibited significant brain permeability 6 hours after oral administration in vivo.

Key Insights:

• The disclosed compounds represent a new class of 5-HT6 receptor inverse agonists.
• Compound 9 shows potential as a therapeutic agent due to its potency, selectivity, and brain penetration.
• The study highlights the critical role of chirality in determining the pharmacological activity of 5-HT6 ligands.

Outlook:

• Further optimization of these non-sulfonamide/non-sulfone compounds could lead to novel therapeutics for neurological and psychiatric conditions.
• Investigating the structure-activity relationships, particularly the impact of stereochemistry, will be essential for future drug development.
• Exploring the therapeutic potential of these selective 5-HT6 inverse agonists in relevant disease models is warranted.